Arrowhead Pharmaceuticals, Inc. (ARWR)

61.60 -2.08 (-3.26%) USD  |  NASDAQ  |  Feb 25, 16:00
61.60 0.00 (0.00%) After-Hours: 20:00
More

Arrowhead Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Sanofi --
Eli Lilly & Co. Upgrade
Cidara Therapeutics, Inc. --
Celcuity, Inc. --